We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The orthosis is a rigid brace used for the purpose of supporting a patient s weak or paralyzed arm to enable and help improve functional activities of daily living, or ADLs, in the home and community.
$1.03
$0.01 (-0.96%)
Price from 8 days ago
The business is unprofitable at the operating level (-35.19% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 25.7%, still solid. Margins contracted 16.1pp, which offsets some of the top-line progress.
ROIC dropped from -21.62% to -32.73%, capital efficiency is deteriorating. Negative free cash flow of -$16M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$41M
▲ +25.7% YoY
Net Income (TTM)
-$15M
▼ -151.9% YoY
Op. Margin
-34.07%
▼ -16.1pp YoY
ROIC
-37.63%
▼ -11.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$15M
▼ -249.5% YoY
Op. Cash Flow (TTM)
-$14M
▼ -341.1% YoY
Net Debt
$6M
Cash & Equiv.
$16M
5Y CAGR: +24.2%
Continue Research